Insider · CIK 0001657568
Paul Campbell
officer
Files at VTRS (Viatris Inc). First filing Nov 12, 2024, latest Nov 12, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $347k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VTRS: Viatris Inc
VTRSOct 9, 2026 · close 17.64
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 6, 2025 | VTRS Viatris Inc | AGrant or award Restricted Stock Unitsderivative | +82,808 | $0.00 | $0 | 82,808 | Mar 10, 2025 |
| Mar 3, 2025 | VTRS Viatris Inc | MOption exercise Common Stock | +17,689 | $0.00 | $0 | 144,590 | Mar 5, 2025 |
| Mar 3, 2025 | VTRS Viatris Inc | FTax withholding Common Stock | -7,916 | $9.33 | $74k | 136,674 | Mar 5, 2025 |
| Mar 3, 2025 | VTRS Viatris Inc | MOption exercise Common Stock | +1,659 | $0.00 | $0 | 138,333 | Mar 5, 2025 |
| Mar 3, 2025 | VTRS Viatris Inc | FTax withholding Common Stock | -727 | $9.33 | $6,783 | 137,606 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Common Stock | +17,872 | $0.00 | $0 | 155,478 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | FTax withholding Common Stock | -7,827 | $9.37 | $73k | 147,651 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Common Stock | +2,379 | $0.00 | $0 | 150,030 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | FTax withholding Common Stock | -1,042 | $9.37 | $9,764 | 148,988 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Common Stock | +17,109 | $0.00 | $0 | 166,097 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | FTax withholding Common Stock | -7,493 | $9.37 | $70k | 158,604 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Common Stock | +727 | $0.00 | $0 | 159,331 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | FTax withholding Common Stock | -319 | $9.37 | $2,989 | 159,012 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Common Stock | +169,238 | $0.00 | $0 | 328,250 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | FTax withholding Common Stock | -74,110 | $9.37 | $694k | 254,140 | Mar 5, 2025 |
| Mar 3, 2025 | VTRS Viatris Inc | MOption exercise Restricted Stock Unitsderivative | -17,689 | $0.00 | $0 | 17,689 | Mar 5, 2025 |
| Mar 3, 2025 | VTRS Viatris Inc | MOption exercise Dividend Equivalent Unitsderivative | -1,659 | $0.00 | $0 | 1,659 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Restricted Stock Unitsderivative | -17,872 | $0.00 | $0 | 0 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Dividend Equivalent Unitsderivative | -2,379 | $0.00 | $0 | 0 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Restricted Stock Unitsderivative | -17,109 | $0.00 | $0 | 34,216 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Dividend Equivalent Unitsderivative | -727 | $0.00 | $0 | 1,452 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | AGrant or award Performance Restricted Stock Unitsderivative | +169,238 | $0.00 | $0 | 169,238 | Mar 5, 2025 |
| Mar 4, 2025 | VTRS Viatris Inc | MOption exercise Performance Restricted Stock Unitsderivative | -169,238 | $0.00 | $0 | 0 | Mar 5, 2025 |
| Nov 11, 2024 | VTRS Viatris Inc | SOpen-market sale Common Stock | -26,925 | $12.88 | $347k | 126,901 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.